Cargando…
In vivo activation of transferred regulatory T cells specific for third‐party exogenous antigen controls GVH disease in mice
Treg cells hold enormous promise for therapeutic application in GVH disease, a lethal complication of allogeneic HSC transplantation. Mouse studies showed that donor‐derived recipient‐specific Treg (rsTreg) cells are far more efficient than polyclonal Treg cells in suppressing GVH disease. However,...
Autores principales: | Martin, Gaëlle H., Grégoire, Sylvie, Landau, Dan A., Pilon, Caroline, Grinberg‐Bleyer, Yenkel, Charlotte, Frédéric, Mège, Jean‐Pierre, Chatenoud, Lucienne, Salomon, Benoît L., Cohen, José L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738555/ https://www.ncbi.nlm.nih.gov/pubmed/23765389 http://dx.doi.org/10.1002/eji.201343449 |
Ejemplares similares
-
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
por: Grinberg-Bleyer, Yenkel, et al.
Publicado: (2010) -
Tumor necrosis factor receptor family costimulation increases regulatory T‐cell activation and function via NF‐κB
por: Lubrano di Ricco, Martina, et al.
Publicado: (2020) -
NF-κB in Cancer Immunity: Friend or Foe?
por: Lalle, Guilhem, et al.
Publicado: (2021) -
Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?
por: Stéphan, Pierre, et al.
Publicado: (2020) -
Tipping the GVH/GVL balance by targeting HIF1α
por: Wu, Yongxia, et al.
Publicado: (2023)